Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.0700 (-1.21%) ($12.6600 - $13.3700) on Fri. Oct. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.85% (three month average) | RSI | 33 | Latest Price | $13.0700(-1.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -8.5% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.925% in a week (0% probabilities). VIXM(-32%) VXX(-26%) UNG(-11%) UUP(-8%) TLT(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.925% (StdDev 3.85%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
1 - 5 Day Possible Target | $-1.74(-113.31%) | Resistance Level | $14.05 | 5 Day Moving Average | $13.06(0.08%) | 10 Day Moving Average | $13.29(-1.66%) | 20 Day Moving Average | $14.05(-6.98%) | To recent high | -17.6% | To recent low | 9.6% | Market Cap | $971m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |